No Data
Cantor Fitzgerald Reiterates Overweight on Keros Therapeutics
Perspective Therapeutics Analyst Ratings
4 Stocks to Watch on Friday: INTU, MSTR and More
Stifel Upgrades Pebblebrook Hotel Trust, Downgrades DiamondRock Hospitality
Loop Capital Maintains Buy on Atkore, Lowers Price Target to $115
A Look at Leslies's Upcoming Earnings Report